Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
ROCHESTER, Mich., Oct. 13, 2026 /PRNewswire/ -- Par Health is recalling 22 lots of Argatroban Injection 250 mg/2.5 mL (100 mg/mL) to the hospital/user level. This recall is being conducted due to the presence of particulate matter, identified as cellulose, polystyrene, polyethylene...
Covered in this story
What has happened since
- Par Technology Corp is up 10.4% since this was published, 7 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $PAR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Par Technology Corp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.